Aemetis
AMTX · NASDAQ
About AMTX
- Employees
- 220
- Headquarters
- Cupertino, California
- Listed
- Jun 1, 2006
- Sector
- Energy
- Industry
- Oil, Gas & Consumable Fuels
- Website
- aemetis.com
AMTX key statistics
- Market cap
- 98.87M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 700.55K
- Volume
- 769.08K
- Open price
- $1.38
- High today
- $1.40
- Low today
- $1.29
- 52 Week high
- $3.80
- 52 Week low
- $1.30
Aemetis (AMTX) at a glance
As of Oct 20, 2026, Aemetis (AMTX) shares are priced at $1.37, giving the company a market cap of 98.87M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.29 and $1.40. The current price is 6.6% above the day's low and 1.8% below its high.
Volume so far is 769.08K shares, in line with the average of 700.55K shares a day.
Over the past year Aemetis has ranged from $1.30 to $3.80, and now sits 3% of the way up that range.
Aemetis met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.13 per share against an estimate of -$0.2805.
The average analyst price target is $13.52, 886.5% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $2.02
- Now
- $1.37
- High
- $29.40
AMTX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 35.3% on average.
- Q3 FY24: reported -$0.38 per share against an estimate of -$0.4292
- Q4 FY24: reported -$0.36 per share against an estimate of -$0.4138
- Q1 FY25: reported -$0.47 per share against an estimate of -$0.4291
- Q2 FY25: reported -$0.41 per share against an estimate of -$0.308
- Q3 FY25: reported -$0.37 per share against an estimate of -$0.2162
- Q4 FY25: reported -$0.08 per share against an estimate of -$0.2162
- Q1 FY26: reported -$0.33 per share against an estimate of -$0.2729
- Q2 FY26: reported -$0.13 per share against an estimate of -$0.2805
AMTX news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Aemetis Praises Unanimous Legislative Passage of California E15 Implementation Legislation
- Press releaseGlobe Newswire
Aemetis Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Aemetis India Subsidiary Begins Biodiesel Deliveries Under $17 Million Allocation from OMCs
- Press releaseGlobe Newswire
Aemetis Sells $18 Million of Section 45Z Clean Fuel Production Tax Credits
- Press releaseGlobe Newswire
Aemetis Receives Key Equipment for Mechanical Vapor Recompression at Ethanol Plant
- Press releaseGlobe Newswire
Nevada's Only Refinery Just Got a Jet-Fuel Makeover Plan
- Press releaseGlobe Newswire
CPCFA Adopts Initial Resolution Supporting up to $1.1 Billion of Tax-Exempt Financing for Aemetis Projects
Similar companies
Companies in the same industry as Aemetis
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.